Visionary Wealth Advisors’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Visionary Wealth Advisors’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-28,435	Closed	-$700K	–	548
2024 Q3	$700K	Sell	28,435 -104	-0.4%	-$2.54K	0.04%	300
2024 Q2	$660K	Buy	28,539 +126	+0.4%	+$2.95K	0.04%	289
2024 Q1	$684K	Buy	28,413 +313	+1%	+$7.34K	0.05%	279
2023 Q4	$647K	Buy	28,100 +1,927	+7%	+$38.7K	0.05%	275
2023 Q3	$533K	Buy	26,173 +6,428	+33%	+$144K	0.04%	287
2023 Q2	$461K	Buy	19,745 +1,428	+8%	+$34.3K	0.04%	304
2023 Q1	$426K	Buy	18,317 +137	+0.8%	+$3.43K	0.04%	299
2022 Q4	$458K	Buy	18,180 +1,717	+10%	+$46.1K	0.04%	251
2022 Q3	$434K	Buy	16,463 +2,031	+14%	+$62.7K	0.05%	245
2022 Q2	$417K	Sell	14,432 -4,695	-25%	-$140K	0.04%	268
2022 Q1	$659K	Buy	19,127 +4,546	+31%	+$161K	0.05%	217
2021 Q4	$639K	Buy	14,581 +2,403	+20%	+$114K	0.05%	205
2021 Q3	$618K	Buy	12,178 +1,121	+10%	+$58.4K	0.06%	168
2021 Q2	$575K	Buy	11,057 +377	+4%	+$17.7K	0.06%	192
2021 Q1	$488K	Buy	10,680 +3,514	+49%	+$172K	0.05%	199
2020 Q4	$329K	Buy	+7,166	New	+$309K	0.04%	223

Other funds holding IDNA

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

FTUS

Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return

CCA

Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Lido Advisors Los Angeles, California $32.7B AUM 19.2% 1-Year Est. Return

Visionary Wealth Advisors's IDNA Position: Q4 2024 in Review

Visionary Wealth Advisors sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q4 2024, closing a stake of 28,435 shares — an estimated $700K sold.

Visionary Wealth Advisors first reported a position in IDNA in Q4 2020 and held it in 16 quarters. The position peaked at $700K in Q3 2024. 58 funds tracked by Wall St. Rank hold IDNA as of Q4 2024.

Visionary Wealth Advisors reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q4 2024 after selling out during the quarter.
Visionary Wealth Advisors sold 28,435 iShares Genomics Immunology and Healthcare ETF shares in Q4 2024, an estimated $700K.
Visionary Wealth Advisors first reported a position in iShares Genomics Immunology and Healthcare ETF in Q4 2020 and held it in 16 quarters.
Visionary Wealth Advisors's iShares Genomics Immunology and Healthcare ETF position peaked at $700K in Q3 2024.
58 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q4 2024.

Based on Visionary Wealth Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.